Effects of phospholipids on antiganglioside antibody reactivity in GBS
- 28 February 2005
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 159 (1-2) , 129-132
- https://doi.org/10.1016/j.jneuroim.2004.09.018
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 10 references indexed in Scilit:
- Binding of immunoglobulin G antibodies in Guillain–Barré syndrome sera to a mixture of GM1 and a phospholipid: Possible clinical implicationsMuscle & Nerve, 2003
- Topology and transport of membrane lipids in bacteriaBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 2000
- Phospholipid biosynthesis in the yeast Saccharomyces cerevisiae and interrelationship with other metabolic processesProgress in Lipid Research, 1999
- Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndromeBrain Research, 1997
- Acute motor axonal neuropathy: An antibody‐mediated attack on axolemmaAnnals of Neurology, 1996
- Guillain-Barré syndrome without sensory loss (acute motor neuropathy)Brain, 1995
- N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndromeAnnals of Neurology, 1994
- Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.The Journal of Experimental Medicine, 1994
- Serum anti‐GQ 1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain‐Barré syndromeNeurology, 1993
- Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndromeAnnals of Neurology, 1992